[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621521":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":10,"responsibleParty":18,"collaborators":20,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":36,"eligibilityCriteria":37,"healthyVolunteers":38,"sex":39,"minAge":40,"maxAge":41,"enrollmentInfo":42,"targetDuration":45,"studyType":46,"phases":10,"briefSummary":47,"conditions":48,"keywords":52,"overallStatus":56,"whyStopped":10,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":10},{"fullName":5,"class":6},"Norwegian Institute of Public Health","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Women attending mammographic screening at three sites in BreastScreen Norway",null,"Those 3-5% with the highest mammographic density in Study A and those with a false positive screening result in Study B will be offered additional imaging with digital breast tomosynthesis within 6 months after the screening examination (A) and an additional standard screening examination after one year (B)",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Solveig Hofvind, PhD, professor","CONTACT","+47 406 45 346","sshh@fhi.no",{"type":19,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[21,24,26,28],{"name":22,"class":23},"Norwegian Cancer Society","OTHER",{"name":25,"class":23},"University Hospital, Akershus",{"name":27,"class":23},"Oslo University Hospital",{"name":29,"class":23},"Vestre Viken Hospital Trust","100621521","personalized-mammographic-screening-in-norway-100621521",false,"NCT07371702","PERsonalized Mammographic Screening in Norway","PERsonalized Mammographic Screening in Norway; Additional Examination for Women With Increased Risk of Breast Cancer","PERMS","Inclusion Criteria:\n\n* invited to screening\n* extremely dense breast (Study A) or a false positive screening result (Study B)\n\nExclusion Criteria:\n\n* Opted out or not signed written consent related to the study\n* Women who have opted out from giving us permission to use screening data for quality assurance and research",true,"FEMALE","50 Years","71 Years",{"count":43,"type":44},3000,"ESTIMATED","2 Years","OBSERVATIONAL","The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening. High-risk women were defined in two studies: Study A; women with high mammographic density, representing approximately 3-5% of screened women, and Study B; women with a false-positive screening result. Women in Study A will be offered an additional screening examination with digital breast tomosynthesis immediately within 6 months after the screening examination. Women in Study B will be offered an additional standard digital mammography examination one year after their initial screening.",[49,50,51],"Breast Cancer","Mammographic Breast Density","Risk Stratification",[53,54,55],"Breast Cancer Screening","personalized screening","breast cancer screening; personalized screening","NOT_YET_RECRUITING","2026-01-27",{"date":59,"type":60},"2026-01-29","ACTUAL",{"date":62,"type":44},"2026-01",{"date":64,"type":44},"2033-12",{"name":5,"class":6}]